Cancer in the elderly population: The protection racket

Journal of Clinical Oncology

Volumn 24, Issue 12, 2006, Pages 1795-1796

  Raghavan, Derek ^a   Suh, Theodore ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CHEMOTHERAPY; COMORBIDITY; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; DRUG CLEARANCE; EDITORIAL; GERIATRIC DISORDER; HUMAN; LIFE EXPECTANCY; PALLIATIVE THERAPY; PATIENT CARE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; AGE; AGED; NEOPLASM; NOTE; POPULATION DYNAMICS; REPRODUCIBILITY; VULNERABLE POPULATION;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; COMORBIDITY; HUMANS; NEOPLASMS; PACLITAXEL; POPULATION DYNAMICS; REPRODUCIBILITY OF RESULTS; VULNERABLE POPULATIONS;

EID: 33646338675     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.4502     Document Type: Editorial

References (5)

1. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 341:2061-2067, 1999
2. Raghavan D, Weiner J, Lipson L: Cancer in the Elderly, in Souhami RL, Tannock IF, Horiot P (eds): Oxford Textbook of Oncology (2nd Ed). London, Oxford, Oxford University Press, 2002, pp 863-874
3. Raghavan D, Grundy R, Greenaway TM, et al: Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: Age itself is not a contra-indication. Br J Urol 62:154-159 1988
4. Findlay M, Griffin A-M, Raghavan D, et al: Retrospective review of chemotherapy for small cell lung cancer in the elderly: Does the end justify the means; Eur J Cancer, 27:1597-1601, 1991
5. Lichtman SM, Mollis DR, Miller AA, et al: Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGN 9762). J Clin Oncol 24:1846-1851, 2006